Skip to main content
Article thumbnail
Location of Repository

Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively?

By Giovanni Tarantino, Patrizia Colicchio, Paolo Conca, Carmine Finelli, Matteo Nicola Dario Di Minno, Marianna Tarantino, Domenico Capone and Fabrizio Pasanisi
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2663560
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2007). A: High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.
    2. (2007). A: Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
    3. (2006). ADOPT Study Group: Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes
    4. (1999). Bodymass index and mortality in a prospective cohort of U.S. adults.
    5. (2007). Borecki IB: Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster? Nutr Metab
    6. (1991). Bosello O: Sonography detection of small intraabdominal fat variations.
    7. (2005). Civeira F: Ultrasonography for the evaluation of visceral fat and the metabolic syndrome. Metabolism
    8. (2007). Comparison of ultrasonographic and anthropometric methods to assess body fat in childhood obesity.
    9. (2009). Could inflammatory markers help diagnose NonAlcoholic Steatohepatitis? Eur J Gastroenterol Hepatol
    10. (2007). CS: Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation
    11. (2007). D'Agostino RB Sr, O'Donnell CJ: Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation
    12. (2008). Goedecke JH: Determinants of insulin-resistant phenotypes in normalweight and obese Black African women. Obesity
    13. (2008). Gong K: Associations of visceral adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean healthy adults. Metabolism
    14. (2008). Häring HU: Identification and characterization of metabolically benign obesity in humans. Arch Intern Med
    15. (2008). Hepatic fat and adenosine triphosphate measurement in overweight and obese adults using 1H and 31P magnetic resonance spectroscopy. Liver Int
    16. (2007). Hosten N: Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging.
    17. (2008). JC: Distribution of Subcutaneous Fat Predicts Insulin Action in Obesity in Sex-specific Manner. Obesity
    18. (2003). Kazil S: Sonographic assessment of changes in thickness of different abdominal fat layers in response to diet in obese women.
    19. (2008). Olefsky JM: Insulin sensitivity: modulation by nutrients and inflammation.
    20. (2005). Pasanisi F: Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy. Ann Nutr Metab
    21. (2008). Pennington CALERIE Team: Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity
    22. (2007). Perrea DN: Sonographic assessment of regional adiposity.
    23. (1985). RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia
    24. (2008). RC: Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children.
    25. (2008). Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology
    26. (2008). YS: Association between low thigh fat and non-alcoholic fatty liver disease.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.